TIDMGSK

RNS Number : 2654L

GlaxoSmithKline PLC

04 September 2019

GlaxoSmithKline plc (the 'Company' and 'GSK')

Awards under the GSK Deferred Investment Award programme

In accordance with the requirements of the EU Market Abuse Regulation the Company today announces a change in the interests of Persons Discharging Managerial Responsibilities ('PDMR') in notional shares of the Company as a result of awards made under the GlaxoSmithKline Deferred Investment Award programme (the 'Programme') on 3 September 2019. The awards under the Programme will vest on 13 February 2022.

Awards are made over notional Ordinary Shares. Vesting is subject to the individuals not having served GSK notice or having been terminated by GSK for cause. The awards will not accrue dividends, and on vesting, will be paid in cash. Executive Directors are not eligible to receive awards under the Programme.

Both awards relate to the PDMRs' employment prior to their being appointed to GSK's Corporate Executive Team.

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                    Ms D Conrad 
====  =======================================  ================================================== 
 b)    Position/status                         SVP, Human Resources 
====  =======================================  ================================================== 
 c)    Initial notification/                   Initial Notification 
        amendment 
====  =======================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  ================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument 
                                                 ISIN: GB0009252882 
====  =======================================  ================================================== 
 b)    Nature of the                           An award of notional Ordinary Shares under 
        transaction                             the Company's Deferred Investment Award 
                                                programme. 
====  =======================================  ================================================== 
 c)    Price(s) and                             Price(s)                  Volume(s) 
        volume(s) 
====  =======================================   ========================  ===================== 
   GBP17.434                                                              10,050 
   =====================================================================  ===================== 
 
 d)    Aggregated information                  N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ============================ 
 e)    Date of the transaction                 2019-09-03 
====  =======================================  ================================================== 
 f)    Place of the                            N/A 
        transaction 
====  =======================================  ================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                    Ms S Jackson 
====  =======================================  ================================================== 
 b)    Position/status                         SVP, Global Communication and CEO Office 
====  =======================================  ================================================== 
 c)    Initial notification/                   Initial Notification 
        amendment 
====  =======================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  ================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument 
                                                 ISIN: GB0009252882 
====  =======================================  ================================================== 
 b)    Nature of the                           An award of notional Ordinary Shares under 
        transaction                             the Company's Deferred Investment Award 
                                                programme. 
====  =======================================  ================================================== 
 c)    Price(s) and                             Price(s)                  Volume(s) 
        volume(s) 
====  =======================================   ========================  ===================== 
   GBP17.434                                                              10,050 
   =====================================================================  ===================== 
 
 d)    Aggregated information                  N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ============================ 
 e)    Date of the transaction                 2019-09-03 
====  =======================================  ================================================== 
 f)    Place of the                            N/A 
        transaction 
====  =======================================  ==================================================

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQZLFBKKFXBBE

(END) Dow Jones Newswires

September 04, 2019 12:37 ET (16:37 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Gsk Charts.